RenaBio Therapeutics
Natick, US · Founded 2023 · Delaware corporation
Founders & leadership
SR
Shengjun RenNamed on SEC filing
RS
Ren ShengjunNamed on SEC filing
Board
ZW
Zhenghua WangBoard director
Y(
Yu (Zoe) ZhangBoard director
HB
Hans BitterBoard director
JM
Jafari MousaBoard director
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 2 rounds · 2024–2025
▶$250KraisedFeb 2025 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedFeb 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Zhenghua WangDirector
- Yu (Zoe) ZhangDirector
- Hans BitterDirector
- Jafari MousaDirector
- Shengjun RenExecutive Officer, Director
- Offering amount
- $4.2M
- Amount sold
- $250K
- Minimum investment
- $5K
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$1MraisedApr 2024 · 18 investors · Other Health CareRule 506(b)
▶$1MraisedApr 2024 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jafari MousaDirector
- Ren ShengjunExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1M
- Minimum investment
- $5K
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has RenaBio Therapeutics raised?
- RenaBio Therapeutics has disclosed $1.3M raised across 2 rounds.
- Where is RenaBio Therapeutics headquartered?
- RenaBio Therapeutics is headquartered in Natick, US.